Sponsor pipeline

UNC Lineberger Comprehensive Cancer Center clinical trial pipeline

Get alerts when UNC Lineberger Comprehensive Cancer Center's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

10 trials changed in the last 30 days: 1 stopped, 5 with notable changes, 4 with minor changes only.

Show 4 trials with minor changes only
  1. Minor

    enCompass · Expanding the Support of Family Caregivers of Diverse · Cancer and Diabetes

    Enrollment closed, study ongoing

    Also in this update: Final enrollment: 118 participants (planned 162); Primary completion date changed from estimate of Nov 1, 2026 to Sep 16, 2026

    UNC Lineberger Comprehensive Cancer CenterNot applicable NCT07061652 Registry history of NCT07061652 on ClinicalTrials.gov (opens the registry)

    Updated

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-09 NCT07867002 Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in… Phase 3 Not Yet Recruiting
2026-10-09 NCT07869368 BLinatumomab and iNKT in Relapsed B-Cell ALL Phase 1 Not Yet Recruiting
2026-09-18 NCT07829146 Feasibility Pilot of AYA-PARTNER Not Yet Recruiting
2026-09-17 NCT07826780 The STRONG Nutrition Support Study for People With Pancreatic Cancer Not Yet Recruiting

Active trials by phase

Early Phase 1
3
Phase 1
18
Phase 1/2
4
Phase 2
26
Phase 3
1
Not charted: 70 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 122

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07867002 Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in… Endometrial Adenocarcinoma Not Yet Recruiting 2026-10-15
Phase 2
NCT07278557 Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia Head and Neck Cancer Recruiting 2026-10-13
NCT07740941 NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma Melanoma (Skin Cancer) Recruiting 2026-09-30
NCT04083495 CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma Peripheral T Cell Lymphoma Recruiting 2026-09-24
NCT05578326 Study of Trilaciclib and Lurbinectidin Lung Cancer Recruiting 2026-09-21
NCT07340541 Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies Breast Cancer Recruiting 2026-09-18
NCT07685938 Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease Chest Wall Tumor Recruiting 2026-09-17
NCT07630168 Effects of Infusion Timing on Treatment Response in Solid Tumors Lung Cancer Recruiting 2026-09-15
NCT06902311 Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous… Breast Cancer Recruiting 2026-09-03
NCT07225114 Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging Breast Cancer Recruiting 2026-06-08
NCT05145400 Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma Multiple Myeloma Recruiting 2026-06-02
NCT05472792 Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation… Breast Cancer Recruiting 2026-05-26
NCT06727773 Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of… Breast Cancer Recruiting 2026-05-06
NCT07276880 Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion… Breast Cancer Recruiting 2026-04-27
NCT07069595 PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease Breast Cancer Recruiting 2026-04-22
NCT03977233 Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer Pancreatic Ductal Adenocarcinoma (PDAC) Recruiting 2026-01-13
NCT07078838 Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1… Endometrial Cancer Not Yet Recruiting 2026-09-28
NCT07605949 Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML Leukemia Acute Myeloid Not Yet Recruiting 2026-09-10
NCT07484139 H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in… Oral Cavity Squamous Cell Carcinoma Not Yet Recruiting 2026-08-31
NCT07545746 Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in… HIV Infections Not Yet Recruiting 2026-08-27
NCT07526597 Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK… Chronic Lymphocytic Leukemia Not Yet Recruiting 2026-08-05
NCT03529422 Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN Larynx Active, Not Recruiting 2026-06-23
NCT04548648 A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas Central Nervous System Lymphoma Active, Not Recruiting 2026-06-10
NCT05911321 Isa-Pom-Dex in Elderly/Frail Subjects With RRMM Multiple Myeloma Active, Not Recruiting 2026-06-09
NCT03174275 Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and… Carcinoma, Squamous Cell Active, Not Recruiting 2026-02-23

Disease areas by active trials, top 10 of 38

Get alerts when UNC Lineberger Comprehensive Cancer Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free